ダウンロード数: 276
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
18_0045.pdf | 1.3 MB | Adobe PDF | 見る/開く |
完全メタデータレコード
DCフィールド | 値 | 言語 |
---|---|---|
dc.contributor.author | 山本, 忠治郎 | ja |
dc.contributor.author | 身吉, 隆雄 | ja |
dc.contributor.author | 並河, 広二 | ja |
dc.contributor.author | 尾上, 泰彦 | ja |
dc.contributor.alternative | Yamamoto, Chujiro | en |
dc.contributor.alternative | Miyoshi, Takao | en |
dc.contributor.alternative | Namikawa, Koji | en |
dc.contributor.alternative | Onoe, Yasuhiko | en |
dc.date.accessioned | 2010-07-06T08:30:57Z | - |
dc.date.available | 2010-07-06T08:30:57Z | - |
dc.date.issued | 1972-01 | - |
dc.identifier.issn | 0018-1994 | - |
dc.identifier.uri | http://hdl.handle.net/2433/121334 | - |
dc.description.abstract | Amphotericin B, one of the polyene macrolide preparations, was administered to 10 cases of prostatic hypertrophy associated with hypertension, cardiac insufficiency or diabetes mellitus in a daily dose of 800~ 1, 200 mg for a period of 2~ 10 weeks. All of these cases were on conservative therapy. The object of the administration was to study the effect of amphotericin B with respect to the reduction of adenoma, improvement of clinical symptoms as well as laboratory results. As a result of the administration, marked reduction of adenoma was observed in one case, moderate reduction in 5 and 3 showed little change in adenoma. Improvement of dysuria and frequency at night was noted in 7 cases, whereas 3 showed little change in the symptoms. Disappearance of residual urine was observed in 4, reduction in 3, and the remaining 3 showed little change in the symptoms. It can be said, consequently, that the administration of amphotericin B produced marked effect in one, effect in 5, moderate effect in one and poor effect in 3. One of 5 cases showing effect was prostatectomied thereafter for histological examination which revealed the sloughing of the glandular epithelium, dilated glandular lumen and granulation-like changes. Atrophy of the glandular structure was not observed. | en |
dc.format.mimetype | application/pdf | - |
dc.language.iso | jpn | - |
dc.publisher | 京都大学医学部泌尿器科学教室 | ja |
dc.publisher.alternative | Department of Urology, Faculty of Medicine, Kyoto Univeersity | en |
dc.subject | Acid Phosphatase/blood | en |
dc.subject | Aged | en |
dc.subject | Alanine Transaminase/blood | en |
dc.subject | Alkaline Phosphatase/blood | en |
dc.subject | Amphotericin B/therapeutic use | en |
dc.subject | Aspartate Aminotransferases/blood | en |
dc.subject | Blood Proteins/analysis | en |
dc.subject | Blood Urea Nitrogen | en |
dc.subject | Chlorine/blood | en |
dc.subject | Cholesterol/blood | en |
dc.subject | Glutamine/blood | en |
dc.subject | Humans | en |
dc.subject | Male | en |
dc.subject | Middle Aged | en |
dc.subject | Nitrogen/blood | en |
dc.subject | Potassium/blood | en |
dc.subject | Prostatic Hyperplasia/drug therapy/pathology | en |
dc.subject | Sodium/blood | en |
dc.subject.ndc | 494.9 | - |
dc.title | 前立腺肥大症に対するPolyene Macrolide投与の影響 | ja |
dc.title.alternative | Effect of polyene macrolide administration on prostatic hypertrophy | en |
dc.type | departmental bulletin paper | - |
dc.type.niitype | Departmental Bulletin Paper | - |
dc.identifier.ncid | AN00208315 | - |
dc.identifier.jtitle | 泌尿器科紀要 | ja |
dc.identifier.volume | 18 | - |
dc.identifier.issue | 1 | - |
dc.identifier.spage | 45 | - |
dc.identifier.epage | 51 | - |
dc.textversion | publisher | - |
dc.sortkey | 10 | - |
dc.address | 日本大学医学部泌尿器科学教室 | ja |
dc.address.alternative | The Department of Urology, Nihon University School of Medicine | en |
dc.identifier.pmid | 4112553 | - |
dcterms.accessRights | open access | - |
dc.identifier.pissn | 0018-1994 | - |
dc.identifier.jtitle-alternative | Acta urologica Japonica | la |
dc.identifier.jtitle-alternative | Hinyokika Kiyo | en |
出現コレクション: | Vol.18 No.1 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。